VYNE Therapeutics Inc.VYNENASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank30
Year-over-Year Change
Return on equity
Latest
-95.38%
↑ 17% vs avg
Percentile
P30
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-115.43%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -95.38% | -24.7% |
| 2024 | -76.48% | -138.5% |
| 2023 | -32.06% | +56.9% |
| 2022 | -74.39% | +50.7% |
| 2021 | -150.77% | +77.9% |
| 2020 | -681.64% | -562.7% |
| 2019 | -102.86% | -160.7% |
| 2018 | -39.46% | -177.4% |
| 2017 | 50.98% | +6.7% |
| 2016 | 47.78% | - |